Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2010
10/07/2010US20100256191 Ampa receptor antagonists and zonisamide for epilepsy
10/07/2010US20100256190 Small-volume oral transmucosal dosage forms
10/07/2010US20100256189 Piperidine derivative
10/07/2010US20100256188 New compounds
10/07/2010US20100256187 Composition of 2,4,6- trifluoro-n-[6-(1-methyl-piperidin-4-carbonyl)-pyridin-2-yl]-benzamide
10/07/2010US20100256186 Sulfonyl-piperidin-4-yl methylamine amide analogs as glyt1 inhibitors, methods for making same, and use of same in treating psychiatric disorders
10/07/2010US20100256185 Crystalline forms of a biphenyl compound
10/07/2010US20100256184 Pharmaceutical composition and administrations thereof
10/07/2010US20100256182 Substituted 1,2,3,4-tetrahydroisoquinoline derivatives
10/07/2010US20100256181 Non-nucleoside reverse transcriptase inhibitors
10/07/2010US20100256180 Fused heterocyclic compounds useful as modulators of nuclear hormone receptor function
10/07/2010US20100256179 Combination therapy for pain in painful diabetic neuropathy
10/07/2010US20100256178 Super-oxide dismutase mimetics
10/07/2010US20100256177 Flavopereirine derivatives for cancer therapy
10/07/2010US20100256176 Method for the preparation of morphine compounds
10/07/2010US20100256175 Treatment for drug addiction
10/07/2010US20100256174 External preparation composition comprising fatty acid-based ionic liquid as active ingredient
10/07/2010US20100256173 Method of Treating Cognitive Impairment
10/07/2010US20100256172 Heteroaryls and uses thereof
10/07/2010US20100256171 Selective serine/threonine kinase inhibitors
10/07/2010US20100256170 Pyrazole compounds useful as protein kinase inhibitors
10/07/2010US20100256169 Administration of tlr7 ligands and prodrugs thereof for treatment of infection by hepatitis c virus
10/07/2010US20100256168 Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta
10/07/2010US20100256167 Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta
10/07/2010US20100256166 Novel Hydantoin Derivatives as Metalloproteinase Inhibitors
10/07/2010US20100256165 Large conductance calcium-activated k channel opener
10/07/2010US20100256164 Pseudobase benzo[c]phenantridines with improved efficacy, stability and safety
10/07/2010US20100256163 Disubstituted phenylpiperdines/piperazines as modulators of dopamine neurotransmission
10/07/2010US20100256162 Piperazine and Piperidine Derivatives
10/07/2010US20100256161 Fibrinogen receptor antagonists and their use
10/07/2010US20100256160 Method of administering an antitumor compound
10/07/2010US20100256159 Stable liquid pharmaceutical composition based on trazodone
10/07/2010US20100256158 Polymorphs of dasatinib and process for preparation thereof
10/07/2010US20100256157 Method of treatment
10/07/2010US20100256156 Heterocyclic compound
10/07/2010US20100256155 Method for inhibiting growth of cancer cells and cell telomere and diseases of cell proliferation by using heteroannelated anthraquinone derivative compounds
10/07/2010US20100256154 Isoxazolo-pyrazine derivatives
10/07/2010US20100256153 Methods for preventing or reducing risk of mortality
10/07/2010US20100256152 Novel pharmaceutical composition for treatment of schizophrenia
10/07/2010US20100256151 Novel salt of 1,3,5-triazine-2,4,6-triamine derivative
10/07/2010US20100256150 Cyclic hydroxylamine as psychoactive compounds
10/07/2010US20100256149 Novel arylamino n-heteraryl compounds as mek inhibitors
10/07/2010US20100256148 Use of cfms inhibitor for treating or preventing bone cancer and the bone loss and bone pain associated with bone cancer
10/07/2010US20100256147 Biaryl acetamide derivatives as modulators of the kinase cascade for the treatment of hearing loss, osteoporosis and cell proliferation disorders
10/07/2010US20100256146 Trisubstituted piperidines
10/07/2010US20100256145 Use of kcnq potassium channel openers for reducing symptoms of or treating disorders or conditions wherein the dopaminergic system is disrupted
10/07/2010US20100256144 Kallikrein 7 modulators
10/07/2010US20100256143 Pharmaceutical compounds
10/07/2010US20100256142 Synthesis of functionalized octahydro-isoquinolin-1-one-8- carboxamides, octahydro-isoquinolin-1-one-8-carboxylic esters and analogs, and therapeutic methods
10/07/2010US20100256141 Novel bis-azaindole derivatives, preparation and pharmaceutical use thereof as kinase inhibitors
10/07/2010US20100256140 Indol-3-yl-carbonyl-piperidin-benzoimidazol derivatives
10/07/2010US20100256139 Anti-Viral Compounds
10/07/2010US20100256138 Benzimidazole derivatives: preparation and pharmaceutical applications
10/07/2010US20100256137 Indazolamide derivatives
10/07/2010US20100256136 Method for Enhancing Pdt Efficacy Using a Tyrosine Kinase Inhibitor
10/07/2010US20100256135 Pyrimido-benzimidzole derivatives and the use thereof in the form of agonists or antagonists of melanocortin receptors
10/07/2010US20100256134 Agent for prevention and/or treatment of skin diseases
10/07/2010US20100256133 Novel compounds having indazole frameworks, methods for preparing the same and pharmaceutical composition comprising the same
10/07/2010US20100256132 Il-12 modulatory compounds
10/07/2010US20100256131 Carbonyl compounds
10/07/2010US20100256130 Morpholinyl and pyrrolidinyl analogs
10/07/2010US20100256129 Selective androgen receptor modulators (sarms) and uses thereof
10/07/2010US20100256128 Gamma secretase modulators
10/07/2010US20100256127 Substituted isoxazoles
10/07/2010US20100256126 Piperidine derivatives as nk3 receptor antagonists
10/07/2010US20100256125 Use of improved toluidine blue in photodynamic therapy
10/07/2010US20100256124 Substituted 1-Methyl-1H-Quinolin-2-Ones And 1-Methyl-1H-1,5-Naphthyridin-2-Ones As Antibacterials
10/07/2010US20100256123 P2x4 receptor antagonist
10/07/2010US20100256122 Butyl and butynyl benzyl amine compounds
10/07/2010US20100256121 Substituted diazepan orexin receptor antagonists
10/07/2010US20100256120 Amide derivatives
10/07/2010US20100256119 Azole derivatives and fused bicyclic azole derivatives as therapeutic agents
10/07/2010US20100256118 Novel adenine compound and use thereof
10/07/2010US20100256117 Hepatocyte growth factor pathway activators in fibrotic connective tissue diseases
10/07/2010US20100256116 Polymorphism in tryptophan hydroxylase-2 controls brain serotonin synthesis
10/07/2010US20100256115 Inhibitors of iap
10/07/2010US20100256114 Amido Compounds And Their Use As Pharmaceuticals
10/07/2010US20100256113 Quinolone derivative
10/07/2010US20100256112 Hydroxythienoquinolones and related compounds as anti-infective agents
10/07/2010US20100256111 Therapeutic agents useful for treating pain
10/07/2010US20100256110 Pharmaceutical solid dispersions
10/07/2010US20100256109 Azetidines As EP2 Antagonists
10/07/2010US20100256108 Indazole acrylic acid amide compound
10/07/2010US20100256107 Preparation composition
10/07/2010US20100256106 Tryptamine sulfonamides as 5-ht6 antagonists
10/07/2010US20100256105 Novel compounds
10/07/2010US20100256104 Novel amide compounds
10/07/2010US20100256103 Novel compounds
10/07/2010US20100256102 C-19 steroids for cosmetic and further uses
10/07/2010US20100256101 Novel bronchodilating alpha, beta-unsaturated isoquinoline amides
10/07/2010US20100256100 Roll-on with high salicylic acid content
10/07/2010US20100256098 Compounds for inhibiting wip1, prodrugs and compositions thereof, and related methods
10/07/2010US20100256097 Inhibitors of janus kinases
10/07/2010US20100256096 Sulfonyl semicarbazides, carbonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arenaviruses
10/07/2010US20100256095 Compounds, methods and pharmaceutical compositions for inhibiting parp
10/07/2010US20100256094 Inositol pyrophosphates, and methods of use thereof
10/07/2010US20100256093 Methods of and compositions for reducing cell death
10/07/2010US20100256092 Boron-containing small molecules
10/07/2010US20100256091 Pharmaceutical powder compositions
10/07/2010US20100256090 Alginic Acid with Low Molecular Weight, Its Salts, Uses, Preparative Methods, Pharmaceutical Compositions and Foods
1 ... 2058 2059 2060 2061 2062 2063 2064 2065 2066 2067 2068 2069 2070 2071 2072 2073 2074 2075 2076 2077 2078 ... 7860